Finance

Lists
Why is OBAT down 6,56%?
Dive Deeper
OBAT:IDX
Brigit Biofarmaka Teknologi Tbk PT
228,00 IDR
-6,56%
(-16,00) 1D
6 ნოე, 16:05:01 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for OBAT...
Open
244 IDR
High
244 IDR
Low
228 IDR
Mkt. cap
155,13 მლრ.
Avg. vol.
489,48 ათ.
Volume
244,80 ათ.
Dividend
3,31%
Quarterly dividend
2 IDR
Ex-dividend date
22 მაი. 2026
P/E ratio
12,18
52-wk high
444 IDR
52-wk low
190 IDR
EPS
19 IDR
Shares outstanding
680,38 მლნ.
No. of employees
17
Open
244 IDR
High
244 IDR
Low
228 IDR
Mkt. cap
155,13 მლრ.
Avg. vol.
489,48 ათ.
Volume
244,80 ათ.
Dividend
3,31%
Quarterly dividend
2 IDR
Ex-dividend date
22 მაი. 2026
P/E ratio
12,18
52-wk high
444 IDR
52-wk low
190 IDR
EPS
19 IDR
Shares outstanding
680,38 მლნ.
No. of employees
17
News stories
From web sources and news partners
Bloomberg.com
Bloomberg.com
·
43 წუთის წინ
Fast-Money Systematic Funds Stoked $2.3 Trillion Tech-Stock Rout
Seeking Alpha
Seeking Alpha
·
1 საათის წინ
SPX/Gold Ratio: Dome Of Doom
Fox Business
Fox Business
·
14 საათის წინ
Stocks plunge as Dem midterm sweep fuels AI regulatory concerns
About Brigit Biofarmaka Teknologi Tbk PT
CEO-
Employees17
Founded2015
Headquarters-
SectorConsumer Staples
IndustryPersonal care products
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
38,18 მლრდ.
45,37 მლრდ.
43,82 მლრდ.
45,18 მლრდ.
Cost of goods sold
18,76 მლრდ.
35,71 მლრდ.
28,17 მლრდ.
28,27 მლრდ.
Cost of revenue
18,76 მლრდ.
35,71 მლრდ.
28,17 მლრდ.
28,27 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,92 მლრდ.
6,42 მლრდ.
10,53 მლრდ.
10,81 მლრდ.
Operating expense
8,67 მლრდ.
7,08 მლრდ.
10,83 მლრდ.
10,70 მლრდ.
Total operating expenses
27,43 მლრდ.
42,80 მლრდ.
39,00 მლრდ.
38,97 მლრდ.
Operating income
10,75 მლრდ.
2,57 მლრდ.
4,83 მლრდ.
6,21 მლრდ.
Other non operating income
-54,54 მლნ.
165,04 მლნ.
242,73 მლნ.
-92,66 მლნ.
EBT including unusual items
10,67 მლრდ.
3,27 მლრდ.
4,87 მლრდ.
5,83 მლრდ.
EBT excluding unusual items
10,69 მლრდ.
3,25 მლრდ.
4,87 მლრდ.
5,83 მლრდ.
Income tax expense
4,46 მლრდ.
2,80 მლრდ.
-
1,39 მლრდ.
Effective tax rate
41,86%
85,71%
-
23,88%
Other operating expenses
751,69 მლნ.
660,16 მლნ.
296,55 მლნ.
-105,38 მლნ.
Net income
2,38 მლრდ.
2,47 მლრდ.
2,92 მლრდ.
4,40 მლრდ.
Net profit margin
6,22%
5,44%
6,65%
9,75%
Earnings per share
-
-
-
-
Interest and investment income
149,39 მლნ.
1,36 მლრდ.
72,42 მლნ.
13,58 მლნ.
Interest expense
-156,33 მლნ.
-1,34 მლრდ.
-266,58 მლნ.
-301,05 მლნ.
Net interest expenses
-6,94 მლნ.
19,56 მლნ.
-194,16 მლნ.
-287,47 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
11,71 მლრდ.
2,63 მლრდ.
5,73 მლრდ.
7,38 მლრდ.
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google აპები